| Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex E Aronica, F Baas, A Iyer, ALMA ten Asbroek, G Morello, S Cavallaro Neurobiology of disease 74, 359-376, 2015 | 95 | 2015 |
| PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation V Chelban, MP Wilson, J Warman Chardon, J Vandrovcova, MN Zanetti, ... Annals of neurology 86 (2), 225-240, 2019 | 75 | 2019 |
| Cx26 partial loss causes accelerated presbycusis by redox imbalance and dysregulation of Nfr2 pathway AR Fetoni, V Zorzi, F Paciello, G Ziraldo, C Peres, M Raspa, F Scavizzi, ... Redox biology 19, 301-317, 2018 | 75 | 2018 |
| Copy number variability in Parkinson’s disease: assembling the puzzle through a systems biology approach V La Cognata, G Morello, V D’Agata, S Cavallaro Human genetics 136, 13-37, 2017 | 68 | 2017 |
| From multi-omics approaches to precision medicine in amyotrophic lateral sclerosis G Morello, S Salomone, V D’Agata, FL Conforti, S Cavallaro Frontiers in Neuroscience 14, 577755, 2020 | 54 | 2020 |
| Histamine regulates the inflammatory profile of SOD1-G93A microglia and the histaminergic system is dysregulated in amyotrophic lateral sclerosis S Apolloni, P Fabbrizio, S Amadio, G Napoli, V Verdile, G Morello, ... Frontiers in immunology 8, 1689, 2017 | 51 | 2017 |
| Neuroinflammation and ALS: transcriptomic insights into molecular disease mechanisms and therapeutic targets G Morello, AG Spampinato, S Cavallaro Mediators of inflammation 2017 (1), 7070469, 2017 | 51 | 2017 |
| Dysregulated miRNAs as biomarkers and therapeutical targets in neurodegenerative diseases G Gentile, G Morello, V La Cognata, M Guarnaccia, FL Conforti, ... Journal of Personalized Medicine 12 (5), 770, 2022 | 44 | 2022 |
| Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS G Morello, M Guarnaccia, AG Spampinato, S Salomone, V D’Agata, ... Scientific reports 9 (1), 9968, 2019 | 43 | 2019 |
| Histaminergic transmission slows progression of amyotrophic lateral sclerosis S Apolloni, S Amadio, P Fabbrizio, G Morello, AG Spampinato, ... Journal of cachexia, sarcopenia and muscle 10 (4), 872-893, 2019 | 40 | 2019 |
| Copy number variations in amyotrophic lateral sclerosis: piecing the mosaic tiles together through a systems biology approach G Morello, M Guarnaccia, AG Spampinato, V La Cognata, V D’Agata, ... Molecular neurobiology 55, 1299-1322, 2018 | 35 | 2018 |
| Molecular mechanisms involved in the protective effect of pituitary adenylate cyclase‐activating polypeptide in an in vitro model of amyotrophic lateral sclerosis G Maugeri, AG D’Amico, DM Rasà, C Federico, S Saccone, G Morello, ... Journal of Cellular Physiology 234 (4), 5203-5214, 2019 | 33 | 2019 |
| Omics data and their integrative analysis to support stratified medicine in neurodegenerative diseases V La Cognata, G Morello, S Cavallaro International Journal of Molecular Sciences 22 (9), 4820, 2021 | 32 | 2021 |
| Deletion of Voltage-Dependent Anion Channel 1 knocks mitochondria down triggering metabolic rewiring in yeast A Magrì, MC Di Rosa, I Orlandi, F Guarino, S Reina, M Guarnaccia, ... Cellular and Molecular Life Sciences 77, 3195-3213, 2020 | 32 | 2020 |
| Molecular taxonomy of sporadic amyotrophic lateral sclerosis using disease-associated genes G Morello, AG Spampinato, S Cavallaro Frontiers in neurology 8, 152, 2017 | 28 | 2017 |
| Selection and prioritization of candidate drug targets for amyotrophic lateral sclerosis through a meta-analysis approach G Morello, AG Spampinato, FL Conforti, V D’Agata, S Cavallaro Journal of Molecular Neuroscience 61, 563-580, 2017 | 25 | 2017 |
| Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy G Morello, S Cavallaro Future medicinal chemistry 7 (10), 1335-1359, 2015 | 21 | 2015 |
| Genetic investigation of amyotrophic lateral sclerosis patients in south Italy: A two-decade analysis C Ungaro, T Sprovieri, G Morello, B Perrone, AG Spampinato, IL Simone, ... Neurobiology of Aging 99, 99. e7-99. e14, 2021 | 20 | 2021 |
| Omics-based exploration and functional validation of neurotrophic factors and histamine as therapeutic targets in ALS C Volonté, G Morello, AG Spampinato, S Amadio, S Apolloni, V D’Agata, ... Ageing Research Reviews 62, 101121, 2020 | 20 | 2020 |
| Differential vulnerability of oculomotor versus hypoglossal nucleus during ALS: involvement of PACAP G Maugeri, AG D’Amico, G Morello, D Reglodi, S Cavallaro, V D’Agata Frontiers in Neuroscience 14, 805, 2020 | 20 | 2020 |
